您要查找的是不是：
- Quinolones, aminoglycosides drugs and containing enzyme inhibitor complex antibacterials (such as SCF) were batter choices to the infection of Non-fermentative bacteria. 結論喹諾酮類(lèi)、氨基糖苷類(lèi)、碳青霉烯類(lèi)藥物以及含酶抑制劑復方型抗菌藥物可為治療非發(fā)酵菌感染的首選藥物。
- enzyme inhibitor complex 酶抑制劑復合體
- Conclusion Administering angiotensin converting enzyme inhibitor orally may be effective for neurally mediated syncope. 結論提示血管緊張素轉化酶抑制劑可能是防治神經(jīng)心原性暈厥發(fā)作的一類(lèi)有效藥物。
- Objective To observe the effect of urokinase(UK) combined with angiotensin converting enzyme inhibitor (ACEI) on IgA nephropathy(IgAN). 目的 觀(guān)察聯(lián)合應用尿激酶(UK)和血管緊張素轉換酶抑制劑(ACEI)苯那普利治療IgA腎病(IgAN)的效果。
- Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor(ACEI) captopril on ischemic myocardium. 目的評價(jià)血管緊張素轉換酶抑制劑(ACEI)卡托普利對缺血心肌的藥理作用。
- Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD? 血管緊張素轉化酶抑制劑和血管緊張素受體拮抗劑聯(lián)合用藥治療CKD是否比單藥應用要好？
- OBJECTIVE:To evaluate the economic effectiveness of three angiotension-converting enzyme inhibitor(ACEI) in treating patients with essential hypertension. 目的:探討3種轉換酶抑制劑治療原發(fā)性高血壓所產(chǎn)生的經(jīng)濟效果。
- Less than one-third of subjects were receiving an angiotensin converting enzyme inhibitor at baseline, although this rose to around 40% by the end of follow-up. 不到三分之一的受試者接受一種血管緊張素轉換酶抑制劑作為基礎用藥，盡管在結束隨訪(fǎng)時(shí)接近40%25。
- Conclusion It is theroretically practicable to administrate T3 or ET antagonist or ET conversing enzyme inhibitor in children with CHD after CPB operation. 結論先心兒童CPB術(shù)后使用T3、內皮素拮抗劑或轉換酶抑制劑在理論上是有根據的。
- Aminoglycoside modifying enzyme is the main resistance mechanism.In this review,some advances in the research of aminoglycoside modifying enzyme inhibitor are summarized. 氨基糖苷類(lèi)抗生素的修飾酶是細菌耐藥的主要機制,本文對氨糖類(lèi)抗生素的修飾酶抑制劑的研究進(jìn)展作一綜述。
- To investigate the effects of perindopril, an angiotensin converting enzyme inhibitor, on mean pulmonary arterial pressure(mPAP) and pulmonary vascular remodeling. 目的探討培哚普利對常壓慢性缺氧高二氧化碳性肺動(dòng)脈高壓及肺血管重建的影響。
- Objective:The aim of this study was to investigate the effects of extra spironolactone on the aldosterone (Aldo) level and heart function in patients with heart failure treated with angiotensin-converting enzyme inhibitor (ACEI). 目的 :觀(guān)察慢性心力衰竭 (心衰 )患者應用血管緊張素轉化酶抑制劑 (ACEI)治療中加用醛固酮受體拮抗劑螺內酯對血漿醛固酮和心功能的影響。
- Aim To determine the effects of angiotensin converting enzyme inhibitor benazepril on reparative fibrosis in two kidney, one clip renovascular hypertensive(2K1C RHT) rat myocardium. 目的觀(guān)察血管緊張素轉換酶抑制劑苯那普利對二腎一夾腎血管性高血壓（2K1C－RHT）大鼠心肌修復性纖維化的影響。
- "Escape" of aldosterone may occur in the treatment of heart failure with angiotensin-converting enzyme inhibitor, thus decreasing the effects of angiotensin-converting enzyme inhibitor. 在心力衰竭治療中應用血管緊張肽轉換酶抑制藥后可發(fā)生醛甾酮“逃逸”，使血管緊張肽轉換酶抑制藥的作用削弱。
- Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? 應用利尿劑、地高辛和血管緊張素轉換酶抑制劑而仍有癥狀的充血性心力衰竭患者加用福洛奎南是否能夠取得進(jìn)一步療效？
- Rats were begun to be treated with angiotensin converting enzyme inhibitor (ACEI)-captopril (75mg/kg/d) or NADPH oxidase inhibitor -apocynin (200mg/kg/d) 24 hours after aorta-construction. AC術(shù)后24小時(shí)開(kāi)始以飲水方式分別給予血管緊張素轉換酶抑制劑Captopril（75mg/kg/d）和NADPH氧化酶抑制劑Apocynin（200mg/kg/d）干預。
- To produce fermented milk that can inhibit the activity of angiotensin converting enzyme(ACE), then the angiotensin converting enzyme inhibitor(ACEI) can be purified from the fermented milk. 用瑞士乳桿菌生產(chǎn)具有抑制血管緊張素轉換酶(ACE)活性的發(fā)酵乳并從其中分離血管緊張素轉換酶抑制劑(ACEI)。
- Conclusion:Angiotensin converting enzyme Inhibitors (ACEI) Was proved to be the most effective drug to set back LVH. 結論:血管緊張素轉換酶抑制劑(ACEI)類(lèi)藥物被證實(shí)為目前最有效的逆轉LVH藥物。
- Semem plasma Elastase and elastase - inhibitor complex Ela/α1 - PI 彈性蛋白酶及酶抑制劑結合物Ela／α1-PI
- Mother and baby interact in a very complex way. 母親與嬰兒以非常復雜的方式相互影響。
